Patient access has never had more technology aimed at it. Benefit checks return in seconds, some prior authorizations clear before the patient leaves the office, and AI agents now wait on hold with payers.
IQVIA's 2026 medicine use report found that, on average, 65% of first-year prescriptions for 99 newly launched medicines went unfilled, most often because payers rejected them. Here are eight technologies reshaping patient access in 2026, where each still needs people, and the question to ask any partner that uses it.
1. Real-Time Benefit Tools and Electronic Benefit Verification
These tools show coverage, patient cost and prior authorization requirements in seconds, either inside the prescriber's EHR or in the hub's workflow. Adoption is mainstream: Surescripts reports that nearly one million prescribers generated 1 billion real-time benefit responses in 2025, and a CMS proposal would require more payers to support real-time benefit standards from October 2027.
Results are strongest for the pharmacy benefit. Infused, in-office and medical-benefit therapies often come back incomplete. For example, at Elusa Health, as a company who supports access programs for specialty products, there are often layers of the approval process that don’t fit within a “prompt” that need specialized human support.
The question to ask: When an electronic check comes back incomplete, who finishes it, and how fast?
2. Electronic Prior Authorization and FHIR-Based APIs
For pharmacy-benefit drugs, electronic prior authorization brings payer questions into the prescriber's workflow, and some requests now auto-approve in a median of 18 seconds when every criterion is met, according to Surescripts. For the medical benefit, CMS requires impacted payers to offer a FHIR-based Prior Authorization API by January 1, 2027, and has proposed extending it to drugs.
However, step therapy exceptions, off-label use and thin documentation still go to manual review, and denials still need an appeal strategy.
The question to ask: Who owns a request once it doesn't auto-approve?
3. AI Voice Agents for Payer Calls
Plenty of benefit and prior authorization work still happens by phone. AI voice agents now place those calls, navigate phone trees, wait on hold, talk to payer representatives and return structured answers. Several vendors now build specifically for pharma patient support hubs.
While voice agents handle scripted questions well, payer answers are inconsistent and calls go off-script. A wrong benefit detail captured with confidence can cost a patient days.
The question to ask: How are AI-collected results checked, and when does a person take over?
4. Generative AI for Documentation and Appeals
Generative AI now reads faxed forms, summarizes charts, and drafts letters of medical necessity and appeals. A March 2026 study of three large language models across 45 prior authorization scenarios found strong clinical content, but the letters consistently missed billing codes, the requested authorization duration and follow-up plans.
However, a clinically strong letter that's administratively incomplete still gets denied. Every draft needs review against the payer's requirements.
The question to ask: Who reviews AI-drafted documents before they reach a payer?
5. Predictive Analytics and Real-Time Reporting
Models trained on case history and payer behavior can flag patients likely to stall, denials worth appealing and patients at risk of never starting therapy. Reporting is also moving from periodic summaries to live case status that brand and access teams can see as it changes.
But a risk score only matters if someone acts on it, and predictions are only as complete as the data shared across hubs, pharmacies and payers.
The question to ask: When a patient is flagged, who acts, and how quickly?
6. Digital Enrollment and Electronic Consent
Enrollment is moving from faxed forms and wet signatures to EHR-embedded forms, web portals and e-signature by text. Required fields mean a case starts complete instead of waiting on a missing signature or insurance card. For example, at Elusa Health, we build our digital enrollment system to strategically capture the necessary fields and automatically cross-check if anything is incorrect. This method makes it easier and faster for providers, with our top four programs seeing a 90% portal utilization rate.
Even in the age of rapid technology adoption, some offices still default to fax. Additionally, some patients can't or won't sign on a phone. Programs need a path for both.
The question to ask: What share of enrollments arrive complete, and how are the rest chased?
7. Copay Program Technology
Virtual debit cards, automated eligibility checks and claims-based detection of copay accumulators and maximizers remove the cost barrier faster. IQVIA's research lead has noted that more than half of patients walk away when told a prescription will cost $250 at the pharmacy.
But benefit designs change every plan year. A patient who is hit with a mid-year copay surprise will likely need someone to rework their assistance quickly.
The question to ask: How early is accumulator or maximizer exposure identified?
8. Patient Engagement: Texting, Portals and Apps
Two-way texting, self-service portals and apps give patients status updates and reminders without a phone call. A CMS proposal would also require payers to share drug prior authorization status through the Patient Access API from October 2027, so patient apps could show it directly.
This is helpful for patients to have a direct line of communication to their care team. But it’s critical that the communication doesn’t become an additional labor in itself.
The question to ask: Can a patient reach someone who knows their case without starting over?
The Technology Is the Easy Part to Buy
Each tool on this list can take time out of a patient's path to therapy. Each also has a handoff point, and that's where access is usually won or lost. When evaluating a partner, look past the feature list and ask how every tool's exceptions are handled.
Want to see which of these technologies belong in your program? Click here.
Frequently Asked Questions
What technologies are used in patient access services?
The main ones in 2026 are real-time benefit tools and electronic benefit verification, electronic prior authorization, AI voice agents, generative AI for documentation, predictive analytics, digital enrollment, copay technology, and patient engagement tools.
Is AI replacing case managers in patient support programs?
No. AI is taking on repeatable work like payer calls, data extraction and first drafts. Exceptions, appeals and patient conversations still need trained people, and AI output needs human review.
Sources referenced
First-year fill and payer rejection rates for new medicines: IQVIA Institute: U.S. Medicine Use Climbs Amid Continued Affordability and Access Challenges, IQVIA, June 2026.
Real-Time Prescription Benefit usage: Surescripts Annual Impact Report 2025 press release, Surescripts, March 2026.
Prior authorization automation approval times: Surescripts Expands Prior Authorization Automation, Surescripts, 2026.
Proposed real-time benefit, drug prior authorization and Patient Access API requirements: 2026 CMS Interoperability Standards and Prior Authorization for Drugs Proposed Rule (CMS-0062-P), CMS, April 2026.
Prior Authorization API deadline: CMS Interoperability and Prior Authorization Final Rule (CMS-0057-F), CMS.
Quality of AI-generated prior authorization letters: AI-Generated Prior Authorization Letters: Strong Clinical Content, Weak Administrative Scaffolding, arXiv, March 2026.
Cost-driven abandonment: Inflation Reduction Act's Impact on Drug Costs, Patient Abandonment, Drug Topics, July 2025.
